| RS2520757556 |
CACNA1F
|
Health Risk |
Pathogenic |
— |
| RS2520757940 |
CACNA1F
|
Health Risk |
Pathogenic |
— |
| RS2520758253 |
CACNA1F
|
Health Risk |
Pathogenic |
— |
| RS2520758970 |
IDS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS2520763530 |
F9
|
Health Risk |
Likely pathogenic |
Thrombophilia, X-linked |
| RS2520775696 |
CACNA1F
|
Health Risk |
Likely pathogenic |
— |
| RS2520780587 |
HPRT1
|
Health Risk |
Pathogenic |
Partial hypoxanthine-guanine phosphoribosyltransferase deficiency, Lesch-Nyhan syndrome |
| RS2520780876 |
HPRT1
|
Health Risk |
Pathogenic |
Lesch-Nyhan syndrome, Lesch-Nyhan syndrome |
| RS2520782845 |
IDS
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS2520785056 |
HPRT1
|
Health Risk |
Likely pathogenic |
Nephrolithiasis/nephrocalcinosis, Nephrolithiasis/nephrocalcinosis |
| RS2520785058 |
IDS
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS2520785174 |
HPRT1
|
Health Risk |
Pathogenic |
Lesch-Nyhan syndrome, Lesch-Nyhan syndrome |
| RS2520785330 |
HPRT1
|
Health Risk |
Pathogenic |
Partial hypoxanthine-guanine phosphoribosyltransferase deficiency, Lesch-Nyhan syndrome |
| RS2520785369 |
HPRT1
|
Health Risk |
Pathogenic |
— |
| RS2520785446 |
IDS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS2520785587 |
IDS
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS2520785646 |
IDS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS2520785671 |
IDS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS2520785689 |
HPRT1
|
Health Risk |
Pathogenic |
Lesch-Nyhan syndrome, Partial hypoxanthine-guanine phosphoribosyltransferase deficiency |
| RS2520789817 |
CACNA1F
|
Health Risk |
Likely pathogenic |
Aland island eye disease, Aland island eye disease |
| RS2520790051 |
F9
|
Health Risk |
Pathogenic |
Hereditary factor IX deficiency disease, Hereditary factor IX deficiency disease |
| RS2520790212 |
F9
|
Health Risk |
Pathogenic |
Hereditary factor IX deficiency disease, Thrombophilia |
| RS2520790255 |
F9
|
Health Risk |
Pathogenic |
Thrombophilia, X-linked |
| RS2520791805 |
CACNA1F
|
Health Risk |
Likely pathogenic |
— |
| RS2520802842 |
F9
|
Health Risk |
Pathogenic |
Thrombophilia, X-linked |
| RS2520803292 |
F9
|
Health Risk |
Likely pathogenic |
F9-related disorder, F9-related disorder |
| RS2520811436 |
IDS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS2520813482 |
HPRT1
|
Health Risk |
Pathogenic |
Partial hypoxanthine-guanine phosphoribosyltransferase deficiency, Lesch-Nyhan syndrome |
| RS2520813885 |
IDS
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS2520813902 |
IDS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS2520815325 |
CACNA1F
|
Health Risk |
Pathogenic |
— |
| RS2520821498 |
HPRT1
|
Health Risk |
Pathogenic |
Lesch-Nyhan syndrome, Lesch-Nyhan syndrome |
| RS2520822018 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS2520823426 |
CACNA1F
|
Health Risk |
Likely pathogenic |
— |
| RS2520823699 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS2520823863 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS2520828047 |
SMC1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 85 |
| RS2520828084 |
SMC1A
|
Health Risk |
Likely pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Developmental and epileptic encephalopathy |
| RS2520828155 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS2520828613 |
SMC1A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 85 |
| RS2520830173 |
HPRT1
|
Health Risk |
Pathogenic |
Lesch-Nyhan syndrome, Partial hypoxanthine-guanine phosphoribosyltransferase deficiency |
| RS2520839064 |
F9
|
Health Risk |
Pathogenic |
Hereditary factor IX deficiency disease, Thrombophilia |
| RS2520839479 |
CACNA1F
|
Health Risk |
Likely pathogenic |
— |
| RS2520839861 |
HPRT1
|
Health Risk |
Pathogenic |
— |
| RS2520840416 |
HPRT1
|
Health Risk |
Pathogenic |
— |
| RS2520840422 |
HPRT1
|
Health Risk |
Pathogenic |
Lesch-Nyhan syndrome, HPRT MICHIGAN |
| RS2520840504 |
HPRT1
|
Health Risk |
Pathogenic |
Lesch-Nyhan syndrome, Lesch-Nyhan syndrome |
| RS2520841758 |
FRMD7
|
Health Risk |
Pathogenic |
— |
| RS2520842805 |
F9
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary factor IX deficiency disease, Thrombophilia |
| RS2520844151 |
F9
|
Health Risk |
Likely pathogenic |
Hereditary factor IX deficiency disease, Hereditary factor IX deficiency disease |
| RS2520844451 |
HPRT1
|
Health Risk |
Pathogenic |
Partial hypoxanthine-guanine phosphoribosyltransferase deficiency, Lesch-Nyhan syndrome |
| RS2520844630 |
F9
|
Health Risk |
Likely pathogenic |
Hereditary factor IX deficiency disease, Hereditary factor IX deficiency disease |
| RS2520845534 |
F9
|
Health Risk |
Likely pathogenic |
Thrombophilia, X-linked |
| RS2520845596 |
F9
|
Health Risk |
Likely pathogenic |
Hereditary factor IX deficiency disease, Hereditary factor IX deficiency disease |
| RS2520845620 |
F9
|
Health Risk |
Pathogenic |
Hereditary factor IX deficiency disease, Hereditary factor IX deficiency disease |
| RS2520845719 |
F9
|
Health Risk |
Pathogenic |
Hereditary factor IX deficiency disease, Thrombophilia |
| RS2520846572 |
F9
|
Health Risk |
Pathogenic |
Hereditary factor IX deficiency disease, Thrombophilia |
| RS2520846740 |
F9
|
Health Risk |
Likely pathogenic |
Hereditary factor IX deficiency disease, Hereditary factor IX deficiency disease |
| RS2520846993 |
F9
|
Health Risk |
Likely pathogenic |
Hereditary factor IX deficiency disease, Hereditary factor IX deficiency disease |
| RS2520848016 |
F9
|
Health Risk |
Likely pathogenic |
Hereditary factor IX deficiency disease, Thrombophilia |
| RS2520848336 |
F9
|
Health Risk |
Likely pathogenic |
Hereditary factor IX deficiency disease, Hereditary factor IX deficiency disease |
| RS2520849107 |
GLA
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2520849314 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS2520850014 |
IDS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS2520850153 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS2520850221 |
GLA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fabry disease, Fabry disease |
| RS2520850302 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS2520851123 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS2520851150 |
IDS
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS2520851203 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS2520851440 |
IDS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS2520851660 |
IDS
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS2520852085 |
CACNA1F
|
Health Risk |
Likely pathogenic |
Aland island eye disease, Aland island eye disease |
| RS2520852344 |
IDS
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS2520852439 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS2520852645 |
GLA
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2520859612 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS2520860264 |
LAMP2
|
Health Risk |
Pathogenic |
Danon disease, Danon disease |
| RS2520861972 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS2520862052 |
IDS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS2520862144 |
IDS
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2520862276 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS2520862342 |
IDS
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS2520862364 |
IDS
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS2520862570 |
IDS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS2520862741 |
IDS
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS2520862765 |
IDS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS2520863301 |
IDS
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS2520863360 |
IDS
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Mucopolysaccharidosis |
| RS2520863392 |
IDS
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS2520863476 |
IDS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS2520863912 |
GLA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fabry disease, Fabry disease |
| RS2520864023 |
GLA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fabry disease, Fabry disease |
| RS2520864097 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS2520864190 |
GLA
|
Health Risk |
Likely pathogenic |
Fabry disease, Fabry disease |
| RS2520864428 |
LAMP2
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2520864754 |
IDS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS2520864961 |
GLA
|
Health Risk |
Pathogenic |
GLA-related disorder, Fabry disease |
| RS2520865089 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS2520865466 |
CACNA1F
|
Health Risk |
Likely pathogenic |
— |